Author

David S. Johnson

Columbia University Irving Medical CenterPrimary ORCID profile (0000-0002-9967-9812 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

David S. JohnsoniD3 papers · GigaGen (United States)

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Brian R. Lawson· 1 shared Danny Jamoul· 1 shared Douglas JuryiD· 1 shared Dritan AgalliuiD· 1 shared Iben Daugaard Krog· 1 shared Irene Munk PederseniD· 1 shared Jakob KörbeliniD· 1 shared Johannes Daugaard Krog· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Brian R. Lawson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Modulating the Novel miR-23b-Wnt/β-catenin Axis Strengthens Endothelial Barrier Properties

Victor Anthony Martinez, Rose E. Presby, Sara Nakanishi, Pallavi Gaur, Ugur Akcan, Johannes Daugaard Krog, Iben Daugaard Krog, Lipi Das, David S. Johnson, Danny Jamoul, Douglas Jury, Brian R. Lawson, Jakob Körbelin, Lewis M. Brown, Vilas Menon, , Irene Munk Pedersen

This study identifies miR-23b as a negative regulator of BBB integrity and shows that anti-miR-23b enhances barrier function through multiple signaling pathways and improves outcomes in a stroke model.

Advanced Science · Jul 30, 2026Peer-reviewedNeuroscience